Where Will IonQ Stock Be in 1 Year?

IonQ’s SkyWater acquisition (about $1.8B in cash/stock) boosts a hypothetical total FY 2026 revenue to ~$900M versus $280M–$290M guided, potentially lowering valuation to ~16–17x sales from ~57x trailing revenue. However, the company remains unprofitable with a ~$254.7M operating loss over the first six months and SkyWater’s gross margin is only ~21%, while dilution is rising (≈24M new shares; ~$450M stock-based comp over the past year). The stock may stay near ~$39 as IonQ integrates businesses and addresses investor trust and competitive positioning concerns.

Analysis

The market is likely to overread the revenue math and underweight revenue quality. Adding low-margin foundry revenue can make the top line look optically cheaper, but it does little for per-share value if the acquired business drags gross margin, consumes management bandwidth, and is funded with stock at a premium valuation. In the next 1-3 months, the stock is more likely to trade on whether the combined company can show cleaner unit economics and slower dilution than on any headline revenue reset.

The second-order winner is the more “pure” quantum story: names like QUBT can benefit if investors decide IonQ is morphing into a roll-up rather than a focused technology winner. That relative-scarcity premium matters because capital is likely to rotate toward whichever company can show the cleanest path from research spend to commercial revenue without an acquisition overhang. The loser is any investor who assumes scale alone will compress the multiple; in this part of the market, the denominator expansion does not matter much if the numerator stays negative.

The key risk is that management uses acquisitions to buy time rather than solve the core profitability problem. If the next combined-quarter print shows continued SBC growth, weak cash conversion, or no evidence that SkyWater is accretive to gross profit, the stock can de-rate back toward the low-30s even if reported revenue stays elevated. Conversely, a sustained move above the post-deal highs would require proof that integration is not just accounting accretion but real margin expansion; absent that, this looks like a fade, not a breakout.

Key Decisions for Investors

• Short IONQ on strength over the next 1-3 months; thesis is that valuation relief from acquired revenue fades once investors refocus on dilution and margin drag. Risk/reward is attractive if the stock cannot reclaim and hold the mid-40s after the next update.
• If options liquidity is workable, buy a 3-6 month IONQ put spread to express downside without taking full borrow risk. Prefer a structure that benefits from a move back toward the low-30s if integration skepticism intensifies.
• Use QUBT as a relative-value long only if you want exposure to the quantum theme; the pair works only if the market continues to penalize conglomerate-like complexity. If QUBT fails to separate on disclosure quality, flatten the trade quickly.
• Set a hard watch item for the next earnings call: consolidated gross margin, SBC as a % of revenue, and cash burn. If any of those improve materially, the short thesis weakens and should be covered.
• No trade for investors without options or borrow access: wait for the first post-acquisition print rather than chasing the revenue headline now.